NCT01048034 2013-10-29Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)Nordic MDS GroupPhase 2 Completed30 enrolled